WO2011000566A2 - Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections - Google Patents

Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections Download PDF

Info

Publication number
WO2011000566A2
WO2011000566A2 PCT/EP2010/003967 EP2010003967W WO2011000566A2 WO 2011000566 A2 WO2011000566 A2 WO 2011000566A2 EP 2010003967 W EP2010003967 W EP 2010003967W WO 2011000566 A2 WO2011000566 A2 WO 2011000566A2
Authority
WO
WIPO (PCT)
Prior art keywords
ch
optionally substituted
group consisting
alkyl
nr
Prior art date
Application number
PCT/EP2010/003967
Other languages
French (fr)
Other versions
WO2011000566A3 (en
Inventor
Dirk Classen-Houben
Oliver Szolar
Peter Sehr
Bernd Wendt
Delphine Gulligay
Stephen Cusack
Joe Lewis
Original Assignee
Savira Pharmaceuticals Gmbh
European Molecular Biology Laboratory (Embl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US22190209P priority Critical
Priority to US61/221,902 priority
Priority to US25111809P priority
Priority to US61/251,118 priority
Application filed by Savira Pharmaceuticals Gmbh, European Molecular Biology Laboratory (Embl) filed Critical Savira Pharmaceuticals Gmbh
Publication of WO2011000566A2 publication Critical patent/WO2011000566A2/en
Publication of WO2011000566A3 publication Critical patent/WO2011000566A3/en

Links